Tag: 上海夜网SV

UW travels to Oregon

first_imgJanelle Gabrielson (6) and the Wisconsin volleyball team hopes to find success this weekend at the Oregon State Invitational.[/media-credit]After hosting its own tournament last week, the Wisconsin volleyball team will play in the Oregon State Invitational this weekend.During their own InnTowner Invitational — which took place at the Field House last weekend — the Badgers went 1-2, sweeping South Dakota, but losing to Duke and Ohio. While the outcome of the tournament was less than ideal, head coach Pete Waite saw improvement throughout the course of the weekend.“I was really pleased with their mental toughness and desire on the court,” Waite said. “I think the people in the stands saw a real improvement and saw that they really were fighting for every point.”Now, the Badgers will head to Oregon State to take on Seattle, Cal State Fullerton and Oregon State. Last year, UW swept Cal State Fullerton at the UNLV Classic at the beginning of the season. However, the Badgers lost to Oregon State in the Marquette Cheese Bowl last season. The loss still lingers in some players’ minds.“I think it’s in some of the returning players’ minds,” sophomore setter Janelle Gabrielsen said. “We would really like to beat them on their home turf. I think if we keep playing like we have been in practice, and we play as a team, then we’ll have a good shot.”For senior outside hitter Brittney Dolgner, though, playing Oregon State means matching up with one of the Pac-10’s top outside hitters, Rachel Rourke. In last year’s match, Rourke overpowered the Badgers, which Dolgner credits to much of the Beavers’ success.“I take it personally because their left side was just killing us,” Dolgner said. “I really just want to get in there and stuff [Rourke] a few times. I just think that if we shut her down, we’ll shut their whole team down.”But with those strong words aside, Dolgner noted that practice has been focusing mostly on defense over the past week, which was one of the Badgers’ weaker points during the tournament last weekend.“We’ve mostly been focusing on blocking,” Dolgner said. “We got beat a lot on the block last weekend so that was one of our main focuses.”“I think they’re really going to bring it to us again,” she continued. “Oregon [State] beat us with a couple good hitters last year, and I think we’ve been working on defending them all week.”But while the Badgers are confident in their attempt to upset Oregon State on its home court, they will have to face a Beavers squad with five returning starters.Wisconsin, on the other hand, has eight new players who have not yet been fully acclimated to the college game. Nevertheless, Dolgner has seen the team improve immensely over the past week, and she feels that the team’s improvement, coupled with a win in the upcoming tournament, would be a huge step for the Badgers.“A win would definitely be great, and just the steps we’ve taken to get to where we are is really great,” Dolgner said. “A lot of people can’t tell the difference between the freshmen and the seniors, and that just shows how much we’ve improved.”Going on the road for the first time this season, the Badgers will enter an environment other than the friendly confines of the Field House. While that may be a daunting task to the younger players on the team, according to Waite, many times a team’s goal can be much stronger on the road when entering a more hostile atmosphere.last_img read more

PreviousFilesRecovery restore previous file versions

first_imgPreviousFilesRecovery: restore previous file versions by Martin Brinkmann on July 14, 2016 in Software – Last Update: July 16, 2016 – 6 commentsPreviousFilesRecovery is a new portable software program for Windows by Nirsoft that displays previous file versions and lets you restore them should the need arise.It is the second program that deals with shadow copies on Windows devices after last month’s ShadowCopyView release by Nirsoft.Unlike ShadowCopyView, PreviousFilesRecovery comes with options to restore previous file versions.That is not the only difference though. Instead of displaying snapshots and associated files on start, it does not display anything on start as it requires configuration first.The first thing you need to do is select a base folder. PreviousFilesRecovery scans the folder and all of its subfolders for previous file versions to display them all in its interface afterwards.PreviousFilesRecoveryThe scan itself is reasonably fast. The selected folder, scan parameters, and the speed of the hard drive are factors that influence the scan speed.While you may leave all settings at their default values to start a scan right after selecting the base folder, it may make sense to change the configuration.Doing so may speed up the scan process, and may reduce the number of results on top of that.The following options are provided by PreviousFilesRecovery in this regard:Change the subfolder depth from unlimited to a level between 1 and 19.Use file filters to limit results to certain types of files.Select whether to “find previous versions of existing files”, “find deleted files”, and “find deleted folders”.Switch from “finding all files with different size or write times, to finding all file versions, or only the latest file version.Scans are considerably faster if you make changes to the search parameters.PreviousFilesRecovery displays all matching files and folders in a table in the lower half of the interface. Each item is listed with its name and path, type (e.g. older file version), current and previous modification date, current and previous file size, and other information.A click on a table column header sorts the listing accordingly, for instance by path or time the copy was created.You may restore any file or folder by right-clicking on it to start the process (or by using the shortcut F8). Note that you may select multiple items for recovery.PreviousFilesRecovery displays a prompt afterwards that you use to select a destination folder for the files. All selected files and folders are copied to that folder when you hit the “do it” button.The program ships with the usual reporting options. You may use them to create HTML reports, or save the data to various formats including XML and plain text.Closing WordsPreviousFilesRecovery is a handy program to restore previous versions of files. You may need to enable the feature on a Windows device before it becomes available. While useful, regular backups are usually better when it comes to backing up and restoring file copies.Still, considering that Windows may create many shadow copies of files, it may provide you with that one version of the file you are after.Summary12345 Author Rating2 based on 3 votes Software Name PreviousFilesRecoveryOperating System WindowsSoftware Category BackupLanding Page http://www.nirsoft.net/utils/previous_files_recovery.html Advertisementlast_img read more

Japanese court rules against journalist in HPV vaccine defamation case

first_img A Japanese court ruled yesterday that a medical journalist who has championed vaccination to reduce the risk of cervical cancer defamed a neurologist by writing that he had fabricated data showing a link between the vaccine and brain damage in mice.The case had been closely watched by vaccine proponents, who worried the decision might embolden those in Japan and elsewhere who claim shots against the human papillomavirus (HPV) cause chronic pain and movement disorders in humans. To their relief, the court in Tokyo didn’t address that question; it only said that Riko Muranaka, a doctor, medical writer, and lecturer at Kyoto University in Japan, had not provided evidence that neurologist Shuichi Ikeda had made up the data behind his controversial claim.The case comes against a backdrop of deep mistrust against the HPV vaccine, introduced in Japan in 2009 and added to the national vaccine program in April 2013. That same year, some vaccine recipients complained about severe side effects. In June 2013, the health ministry suspended its recommendation that all girls in their early teens receive the vaccine, causing the vaccination rate to drop from 70% for girls born in the mid-1990s to 1% today. The health ministry has also funded research and set up advisory panels to study the alleged side effects. By Dennis NormileMar. 27, 2019 , 4:00 PM Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Takuma Suda Riko Muranaka did not provide evidence that research data were fabricated, a court in Tokyo said. In March 2016, Ikeda, a neurologist at Shinshu University in Matsumoto, Japan, showed one such panel data purportedly showing brain damage in a mouse given the HPV vaccine. He repeated the claim for a news crew later the same day.In the June 2016 issue of the business magazine Wedge, Muranaka claimed Ikeda had not performed the experiments himself; she also said only a single mouse had been given the vaccine, and that a slide purportedly showing brain damage in Ikeda’s presentation didn’t come from that mouse. “The inescapable conclusion is that there was an ‘intention of fabrication,’” wrote Muranaka, who in 2017 was awarded the John Maddox Prize for Standing up for Science.The magazine article triggered an investigation by Shinshu University, which concluded in November 2016 that Ikeda had presented preliminary results based on an experiment with one mouse as “scientifically proven.” Japan’s health ministry issued a statement saying Ikeda’s results “have not proven anything about whether the symptoms that occurred after HPV vaccination were caused by the HPV vaccine,” and blasting him for his “very regrettable” responsibility in “causing misunderstanding among citizens.”But the court sidestepped questions about the vaccine itself and ruled that Muranaka had not provided convincing evidence of fabrication. Muranaka and the magazine will have to pay Ikeda 3.3 million yen (about $29,900), plus part of his legal expenses. They also must post an apology and delete portions of the online article.Ikeda welcomed the ruling, saying a charge of fabrication would leave him “unable to address academic society,” according to press reports of a postruling press conference. He seemed to downplay the significance of what he said previously about the mouse experiments, arguing they were just one way to clarify why some vaccine recipients suffer brain disorders.“I am sorry to hear [the] Tokyo district court ignored science and [the] public interest,” Muranaka wrote in a statement posted online. However, “This decision has nothing to do with the safety of the HPV vaccines,” she noted. Women who saw Ikeda’s presentation on TV and decided against vaccination “lost the chance to protect their life and health,” Muranaka wrote. She told Science that she will appeal. “I must win this case for the sake of  freedom of scientific speech and sound science,” she says.  Email “I must win this case for the sake of  freedom of scientific speech and sound science.”  Japanese court rules against journalist in HPV vaccine defamation case Click to view the privacy policy. Required fields are indicated by an asterisk (*) Riko Muranaka The battle over HPV vaccines in Japan is set to continue. Vaccinees have brought class action lawsuits against two vaccine producers and the health ministry seeking damages for alleged side effects. Those suits are expected to drag on for years.Meanwhile, evidence for the safety and efficacy of the three HPV vaccines on the worldwide market continues to grow. In a July 2017 update, for instance, the World Health Organization’s Global Advisory Committee on Vaccine Safety noted that at the time 270 million doses of HPV vaccines had been distributed. There is “no evidence to suggest a causal association” between the HPV vaccine and the various syndromes or symptoms reported as side effects, the update states, adding that the committee “considers HPV vaccines to be extremely safe.” As for efficacy, the update noted that countries that have included HPV vaccines in national immunization programs have seen a 50% decrease in the incidence of cervical precancerous lesions among younger women.Whether the verdict will have any impact outside Japan remains to be seen. “I think what is important is that media coverage does not distort the point and imply Dr. Ikeda’s science won: It was Dr. Muranaka’s manners and language that lost,” says Heidi Larson, director of the Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine.*Correction, 28 March, 5:05 a.m.: The headline of this story has been adjusted to show the court did not find the defendant guilty, though it did rule in favor of the plaintiff in a civil defamation suit. Sign up for our daily newsletter Get more great content like this delivered right to you! Countrylast_img read more